Catalyst Funds Management Pty LTD Avanos Medical, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 1,200 shares of AVNS stock, worth $23,387. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,200Holding current value
$23,387% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AVNS
# of Institutions
274Shares Held
42.4MCall Options Held
5.4KPut Options Held
5K-
Black Rock Inc. New York, NY7.01MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$104 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$61.8 Million3.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$50.5 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.37MShares$46.1 Million0.03% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $906M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...